ERBB2 and neoplasm: In this context, the aim of the present study is to analyze the expression/gene amplification as well as the distribution of HER2 in our large EAC cohort in correlation to the corresponding clinicopathological data, with the aim to verify the incidence and prognostic impact in this specific tumor subgroup.